Theralase appoints Cordoba as Therapeutic Division GM

March 21, 2011
Toronto, ON, Canada--Theralase announced that Jorge Córdoba has been appointed as general manager - Therapeutic Division for its therapeutic medical laser products.

Toronto, ON, Canada--Theralase Technologies (TSXV: TLT) announced that effective immediately, Jorge Córdoba has been appointed as general manager - Therapeutic Division for Theralase’s line of proprietary therapeutic medical laser products. Córdoba, reporting to Roger Dumoulin-White, president and CEO, will have general management responsibilities over the sales, marketing, production, clinical services and regulatory affairs departments.

Córdoba has over 16 years of experience in leading numerous high-technology manufacturing companies to success, providing general management expertise in local and international sales, marketing, production, operations and regulatory affairs. His last position was as director of operations for a $17 million aerospace organization turnaround situation, in which Córdoba, through a number of different initiatives, achieved an increase in productivity of over 400% in less than 2 years. Prior to that, Córdoba successfully launched a 250,000 square foot, $40 million facility for manufacturing high precision assemblies for a division of Magna Inc. In an earlier position, he was the sales and marketing manager for a high tech equipment manufacturer, responsible for sales in excess of $10 million annually.

“I am excited to be part of such a world-class medical organization as Theralase. Under the direction of Roger Dumoulin-White, Theralase has systematically developed valuable intellectual property in the medical laser space and in my estimation is now positioned to rapidly execute on its growth strategy,” said Córdoba. “I accepted the position because Theralase has such wonderful upside, attracting a dedicated team of professionals able to take this intellectual property to the next level and dramatically increase its revenue over the next few years. I look forward to following in Roger’s footsteps to dramatically grow the therapeutic division of the Company.”

Córdoba obtained a Master’s of Business from the Ivey School of Business, University of Western Ontario, London, Ontario in 2005, a Master’s of Science in Advanced Manufacturing Technology from the University of Manchester, Manchester, England in 1993 and a Bachelor of Mechanical-Electrical Engineering from the National University, Mexico City, Mexico in 1989.

SOURCE: Theralase; www.theralase.com/press/TLT_Operations_Manager-03-21-2011.pdf

Posted by:Gail OvertonSubscribe now to Laser Focus World magazine; It’s free! Follow us on TwitterFollow OptoIQ on your iPhone. Download the free App here

Sponsored Recommendations

Melles Griot Optical Systems and Semrock Optical Filters for Spatial Biology

Feb. 26, 2025
Discover why a robust, high-throughput fluorescence imaging system with Semrock optical filters is key for Spatial Biology.

Working with Optical Density

Feb. 26, 2025
Optical Density, or OD, is a convenient tool used to describe the transmission of light through a highly blocking optical filter.

Finding the Right Dichroic Beamsplitter

Feb. 26, 2025
Unsure how to select the right dichroic beamsplitter? Explore our selection guide for our wide variety of 45º dichroic beamsplitters.

Measurement of Optical Filter Spectra

Feb. 26, 2025
Learn about the limitations of standard metrology techniques and how Semrock utilizes different measurement approaches to evaluate filter spectra.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!